Clinical Trial Detail

NCT ID NCT03217669
Title Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Chao Huang
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Epacadostat + Sirolimus

Age Groups: adult senior

No variant requirements are available.